Johnson & Johnson

NYSE : JNJ

$255.56−0.66%

Financials

Income statement · full history

USD in millions · per-share amounts unscaled. Each period shows the value from the latest filing that prints it.

Income statement, full reported history for 0000200406. USD in millions · per-share amounts unscaled. Each period shows the value from the latest filing that prints it.
Reported line item	Jan 2, 2017 to Dec 31, 2017	Jan 1, 2018 to Dec 30, 2018	Dec 31, 2018 to Dec 29, 2019	Dec 30, 2019 to Jan 3, 2021	Jan 4, 2021 to Jan 2, 2022	Jan 3, 2022 to Jan 1, 2023	Jan 2, 2023 to Dec 31, 2023	Jan 1, 2024 to Dec 29, 2024	Dec 30, 2024 to Dec 28, 2025
Sales to customers	76,450	81,581	82,059	82,584	78,740R	79,990R	85,159	88,821	94,193
Cost of products sold	25,439R	27,091	27,556	28,427	23,402R	24,596R	26,553	27,471	30,256
Gross profit	51,011R	54,490	54,503	54,157	55,338R	55,394R	58,606	61,350	63,937
Selling, marketing and administrative expenses	21,520R	22,540	22,178	22,084	20,118R	20,246R	21,512	22,869	23,676
Research and development expense	10,594R	10,775	11,355	12,159	14,277R	14,135R	15,085	17,232	14,665
In-process research and development impairments	408	1,126	890	181	900	783	313	211	81
Interest income	(385)	(611)	(357)	(111)	(53)	(490)	(1,261)	(1,332)	(1,056)
Interest expense, net of portion capitalized	934	1,005	318	201	183	276	772	755	971
Other (income) expense, net	(42)R	1,405	2,525	2,899	526R	810R	6,634	4,694	(7,209)
Restructuring	309	251	266	247	209R	275R	489	234	228
Earnings before provision for taxes on income	17,673	17,999	17,328	16,497	19,178R	19,359R	15,062	16,687	32,581
Effective Rate	16,373	2,702	2,209	1,783	1,377R	2,989R	1,736	2,621	5,777
Net earnings from continuing operations					17,801	16,370	13,326	14,066	26,804
Net earnings from discontinued operations					3,077	1,571	21,827	0	0
Net earnings	1,300	15,297	15,119	14,714	20,878	17,941	35,153	14,066	26,804
Basic net earnings per share from continuing operations (in dollars per share)					6.76	6.23	5.26	5.84	11.13
Basic net earnings per share from discontinued operations (in dollars per share)					1.17	0.60	8.62	0.00	0.00
Basic (in dollars per share)	0.48	5.70	5.72	5.59	7.93	6.83	13.88	5.84	11.13
Diluted net earnings per share from continuing operations (in dollars per share)					6.66	6.14	5.20	5.79	11.03
Diluted net earnings per share from discontinuing operations (in dollars per share)					1.15	0.59	8.52	0.00	0.00
Diluted (in dollars per share)	0.47	5.61	5.63	5.51	7.81	6.73	13.72	5.79	11.03
Basic (in shares)	2,692	2,681.5	2,645.1	2,632.8	2,632.1	2,625.2	2,533.5	2,407.3	2,407.4
Diluted (in shares)	2,745.3	2,728.7	2,684.3	2,670.7	2,674	2,663.9	2,560.4	2,429.4	2,429.4

History starts FY2017, the period ended Dec 31, 2017 — the earliest period our structured-data source covers, not the company’s first year.

23 reported lines · 9 periods · values taken from the latest filing that prints each period.

R23 restated by the filer — hover for the figure as first reported.
— the filer printed the line and left the period empty. An empty cell means the line was not printed at all; it is never a zero.

179 of 183 values link to the exact element in the filer’s own document.

Every line and every caption is the company’s own. Each period carries the value from the latest filing that prints it, which is why a restated period shows the restated number with the figure as first reported kept underneath.

Nothing on this table is computed by us: no fourth quarter, no growth rate, no margin. Marks describe the filer’s own restatements.